Name: SNDX Balance Sheet - Syndax Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SNDX - Syndax Pharmaceuticals Inc.

USD | NASDAQ | Healthcare

SNDX Balance Sheet - Syndax Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013
Cash And Short Term Investments
Cash And Equivalents	134.9	154.1	295.4	74.4	222.0	115.2	24.6	33.8	35.2	23.8	23.2	10.0	10.1
Restricted Cash	0.1	0.2	0.2	0.1	0.1	0.1	-	0.2	0.2	0.3	0.1	-	-
Short Term Investments	259.1	418.8	275.3	401.4	218.0	177.8	35.2	47.1	94.8	81.5	63.3	-	-
Cash And Short Term Investments	394.1	572.9	570.7	475.8	439.9	293.1	59.8	80.9	130.0	105.3	86.5	10.0	10.1
Receivables
Accounts Receivable	38.0	7.6	0.0	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	32.8	0.4	0.0	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	13.5
Non-Current Assets
Property, Plant & Equipment Gross	0.6	0.4	0.4	0.4	0.7	0.6	0.6	0.6	0.5	0.5	0.3	-	-
Accumulated Depreciation
Current Liabilities
Accounts Payable	16.6	11.6	10.0	4.4	5.7	3.5	6.2	1.4	2.2	2.4	1.5	-	-
Short Term Debt	350.0
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	-
Supplementary Data
Total Debt	350.0	337.9	0.0	-	-	-	-	-	-	-	-	-	-
Net debt	(44.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	130.9	134.9	116.8	108.6	154.0	-	133.0	105.4	114.6	295.4	94.6	97.3	57.5	74.4	71.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	34.9	32.8	25.0	17.7	4.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	16.1	13.5	9.5	9.9	8.5	-	4.9	4.2	4.7	3.3	3.7	3.1	1.9	1.9	2.3	2.4	9.0	1.5
Other Current Assets	-	-	-	-	-	-	3.5	9.6	6.1	0.0	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	471.2	528.1	529.8	531.7	548.8	-	414.8	446.1	453.9	580.9	381.0	409.1	441.5	489.8	357.6	392.3

Non-Current Assets
Property, Plant & Equipment Gross	0.6	0.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	0.4	0.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	0.2	0.2	0.1	0.0	0.0	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3
Long Term Investments	-	-	20.1	62.6	89.9	-	10.0	29.5	87.4	29.8	15.7	19.5	16.6	5.5	-	12.1	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	1.2	1.3	1.5	1.6	1.8	1.5	0.8	1.0	1.2	1.5	1.7	2.0	0.9	1.0	1.2	0.8
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	-	-	-	-	-	-	0.0	0.2	0.2	0.5	0.6	0.6	0.7	0.8	0.9	1.0	1.0
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	472.7	529.7	551.8	596.1	640.7	-	425.8	476.9	543.0	612.9	399.2	431.3	459.8	497.2	359.7	406.4	422.2

Current Liabilities
Accounts Payable	10.8	16.6	13.8	17.4	10.0	-	4.9	11.6	8.8	10.0	6.0	11.0	8.1	4.4	7.1	6.4	8.2	5.7	5.1	3.6	6.5	3.5	3.8	1.8	9.0	-	6.8	2.3	4.4	1.4	3.2	5.3	2.6	2.2	2.2	3.4	2.7	2.4	2.0	1.6
Short Term Debt	350.0	350.0	327.1	330.6	335.9	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.5	0.5	0.3	0.3	0.4	-	0.8	1.0	1.0	1.0	1.0	1.0	0.5	0.4	0.5	0.3
Accrued Expenses	6.8	24.4	15.6	14.5	7.4	-	11.6	7.8	4.6	11.2	7.9	5.6	3.1	5.9	4.0	2.7	1.9	4.3
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	86.2	120.1	114.2	113.0	94.6	-	59.4	42.5	50.8	58.1	39.2	30.2	23.7	29.1	20.8

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	-	-	-	-	0.0	0.1	0.3	0.6	0.9	1.1	0.6	0.7	0.8	0.6
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	344.9	345.0	322.2	325.7	331.1	-	0.0	0.1	0.3	0.6	0.9	1.1	0.6	0.7	0.8	13.6
Total Liabilities	431.0	465.1	436.4	438.7	425.6	-	59.4	42.6	51.1	58.7	40.0	31.3	24.3	29.8	21.6	44.5

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(1,549.3)	(1,506.6)	(1,438.6)	(1,377.9)	(1,306.0)	-	(1,127.0)	(1,042.9)	(974.8)	(902.4)	(829.9)	(778.8)	(734.2)	(693.0)	(653.8)	(618.4)	(580.9)
Accumulated Other Comprehensive Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	41.6	64.6	115.4	157.4	215.1	-	366.4	434.3	491.9	554.2	359.2	400.0	435.5	467.4	338.1	361.9	374.5
Total Equity	41.6	64.6	115.4	157.4	215.1	-	366.4	434.3	491.9	554.2	359.2	400.0	435.5	467.4	338.1	361.9	374.5	408.4